S'abonner

Intense symptoms of pain are associated with poor sleep, fibromyalgia, depression and sleep apnea in patients with rheumatoid arthritis and psoriatic arthritis. A register-based study - 01/10/24

Doi : 10.1016/j.jbspin.2024.105744 
Lauri Weman a, , Henri Salo b, Laura Kuusalo c, Johanna Huhtakangas d, Paula Vähäsalo e, Maria Backström f, Johanna Kärki g, Tuulikki Sokka-Isler a, h
a University of Eastern Finland, Kuopio, Finland 
b Data and Analytics, Finnish institute for health and welfare (THL), Helsinki, Finland 
c Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Turku, Finland 
d Division of Rheumatology, Kuopio University Hospital, Kuopio, Finland 
e Research Unit of Clinical Medicine, University of Oulu, Department of Children and Adolescents, Oulu University Hospital, Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland 
f Department of Pediatrics, Wellbeing Services County of Ostrobothnia, Vaasa, Finland, Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland 
g Department of Children and Adolescents, Kanta-Häme Central Hospital, Hämeenlinna, Finland 
h University of Eastern Finland and Rheumatology, Hospital Nova of Central Finland, Jyväskylä, Finland 

Corresponding author.

Highlights

Sixteen percent of patients with RA and 22% with PsA had sleeping problems during the last week.
Patients who had sleeping problems also had three times higher pain, fatigue and patient global activity.
Sleeping problems were independently associated with pain, along with comorbid fibromyalgia for both diseases. Depression was independently associated in RA patients and sleep apnea in PsA patients.

Le texte complet de cet article est disponible en PDF.

Abstract

Objectives

To study whether poor sleep and comorbidities are associated with high symptom levels of patient-reported outcomes (PROs) pain, patient global assessment and fatigue in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA), in a nation-wide cross-sectional setting.

Methods

Clinical data were extracted from The Finnish Rheumatology Quality Register between 1.2021 and 9.2022. Self-reported sleep was categorized as “good” (little/no difficulties) or “poor” (great difficulties/can’t) sleep. Data concerning comorbidities were collected from national registers. Descriptive statistics were used. Regression analyses were applied to analyze independent associations of sleep status, comorbidities and disease activity with pain in RA and PsA, adjusting for age and sex.

Results

Among 13,512 patients with RA, 6052 [mean (SD) age 62 (13), 71% female] had sleep status reported; in PsA 1861/3636 [age 55 (13), 48% female]. In RA, 5072 (84%) reported good and 980 (16%) poor sleep; the corresponding numbers in PsA were 1460 (78%) and 401 (22%). Median values for objective disease activity were low and similar in patients with poor sleep and good sleep in both diseases. Among patients with no swollen joints, the median values for PROs were approximately three times higher for patients with poor sleep vs. good sleep in both diagnoses (P<0.001). In regression analyses, “poor” sleep was independently associated with higher symptoms in pain [B (95%CI) 20 (18,22) in RA and 23 (19, 26) in PsA], followed by comorbid fibromyalgia, as well as depression in RA and sleep apnea in PsA.

Conclusion

“Poor” sleep quality and comorbidities are independently associated with pain. Patient's sleep status is important to know especially in patients with severe symptoms without objective disease activity.

Le texte complet de cet article est disponible en PDF.

Keywords : Rheumatoid arthritis, Psoriatic arthritis, Sleep, Patient-reported outcomes, Fibromyalgia, Depression, Sleep apnea


Plan


© 2024  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 91 - N° 5

Article 105744- septembre 2024 Retour au numéro
Article précédent Article précédent
  • Limb arteries involvement assessed by FDG/PET CT at diagnosis of giant cell arteritis and risk of relapse: An observational study
  • Geoffroy Peyrac, Arthur Mageau, Augustin Gaudemer, Khadija Benali, Julien Rohmer, Jean-Francois Alexandra, Andrey Strukov, Sebastien Ottaviani, Thomas Papo, Karim Sacre
| Article suivant Article suivant
  • Skeletal muscle mass and quality in gout patients versus non-gout controls: A computed tomography imaging study
  • Allyson Covello, Michael Toprover, Cheongeun Oh, Gregoire Leroy, Ada Kumar, Brian LaMoreaux, Michael Mechlin, Theodore R. Fields, Michael H. Pillinger, Fabio Becce

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.